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1.1 Problem Statement 
Salmonella enterica (S. enterica) is a facultative, intracellular, gram-negative 
bacterium that causes serovar-specific disease in a range of hosts. In the human host, S. 
enterica serovars may cause typhoidal as well as non-typhoidal illness, both with 
significant global distribution. Non-typhoidal S. enterica causes gastroenteritis and is 
responsible for over 78 million cases globally of foodborne illness each year 1. 
Salmonella enterica serovar Typhi (S. Typhi) is a human-specific pathogen and the 
primary etiologic agent of typhoid fever. S. Typhi infections are responsible for an 
estimated 21 million new infections each year, resulting in 200,000 deaths. Typhoid fever 
is an acute illness, frequently characterized by high fever, malaise, and abdominal pain. S. 
Typhi is of high clinical relevance in the regions of South-central Asia, South-eastern 
Asia, and Southern Africa 1. 
 
 Infection by S. Typhi is most commonly caused by the consumption of 
contaminated food or water. Once ingested, S. Typhi crosses the intestinal epithelial 
barrier where it is phagocytosed by macrophages, but replicates within these cells to 
achieve systemic infection. Common sites of the bacterium within the host include bone 
marrow, spleen, liver, and pancreas. From the liver, the bacterium is also able to transit to 
the gallbladder, the storage site for bile, through the vasculature or the ducts that emanate 







With appropriate treatment, most patients recover from the acute stage of the 
disease; however, 3-5% of individuals infected with S. Typhi develop a chronic infection 
in the gallbladder. An epidemiological study found that an important factor in the 
development of chronic gallbladder carriage is the presence of cholesterol gallstones – 
which can be found in 80-90% of carriers 3. We have demonstrated that S. Typhi 
mediates carriage through the formation of biofilms on the surface of cholesterol 
gallstones in the gallbladder (Figure 1) 2. 
 
 Biofilms are organized multicellular communities encapsulated in an 
extracellular polymeric substance (EPS), comprised of secreted and cell wall-associated 
polysaccharides, proteins, and extracellular DNA. Bacteria within a biofilm are protected 
from external (e.g. antibiotics) and internal (e.g. innate immune response) factors 4, 5. 
Biofilm development is characterized by sequential events which include surface 
attachment, secretion of the EPS, and dispersal of community members to the 
environment 6. Biofilms in the intestine or gallbladder may also play a role in persistence 
of non-typhoidal gastroenteritis-causing Salmonella serovars.  
 
The spread of S. Typhi can be linked to the carrier state during which fecal 
shedding allows the bacteria to be acquired by hosts through contaminated food/water. 
Individuals that become chronic S. Typhi carriers are asymptomatic and are direct threats 
to public health as they can unknowingly shed the bacteria in their feces and urine. 
Therefore, these patients often serve as critical reservoirs for maintaining the pathogen in 






of gallstones, is a crucial predisposing factor for the development of gallbladder cancer 7. 
Because biofilm formation on cholesterol gallstones is a hallmark of chronic carriage, 
treating this state is extremely difficult and ineffective. Traditional therapy for carriage 
includes an antibiotic regimen with a cholecystectomy; however, while surgical 
gallbladder removal can be considered, in developing nations where typhoid is most 
prevalent, this invasive therapy is unavailable as a means for bacterial eradication.   
 
The impact that chronic carriage has on human health, combined with the high 
global incidence of typhoid fever, highlights the significance of this research. This project 
is part of an ongoing effort to characterize the chronic carrier state of S. Typhi – with the 
goal of determining the mechanisms of chronic, asymptomatic S. Typhi carriage. This 
project examined clinical isolates from confirmed acute and chronic S. Typhi infections 
in a variety of biological, genetic, and molecular assays. The findings of this research will 
pave the way for targeted drug therapies that have the potential to reduce or eliminate the 
chronic carrier state of S. Typhi, thus alleviating the burden of typhoid fever.  
 
1.2 Hypothesis and Rationale 
We hypothesize that phenotypic and genomic differences exist between acute and 
chronic clinical isolates of S. Typhi. If the functional, molecular, or genetic 
characteristics of the strains differ, it may suggest that strain variations are linked to the 
ability to establish carriage. This hypothesis was examined through the following aims: 
1. Examination of biofilm formation of acute and chronic strains. 
2. Comparison of the exopolysaccharide matrix components of acute and chronic strains. 








Materials and Methods 
2.1 Bacterial Strains and Growth Conditions 
 The bacterial strains used in this study were wild-type (WT) S. Typhi Ty2 
(JSG698), S. Typhimurium ATCC 14028 (JSG210), and S. Typhi clinical isolates from 
patients with either an acute or chronic typhoidal infection (Table 1). All clinical S. Typhi 
isolates tested positive by Vi-antigen agglutination test before use in this study. The 
strains were streaked on Luria-Bertani (LB) agar plates and incubated at 37 ˚C overnight. 
Single colonies were used to start overnight (O/N) liquid cultures. Planktonic cells were 
grown at 37 ˚C on a rotating drum in LB or tryptic soy broth (TSB). Antibiotics, when 
needed, were used at the following concentrations: chloramphenicol, 25 µg/ml; 
ampicillin, 100 or 200 µg/ml, kanamycin, 45 µg/ml; and streptomycin, 100 µg/ml. The 
deletion of ∆tviB was generated by the λ-Red mutagenesis method 8 with the following 
primers: upstream primer JG2934 
(ataaaattttagtaaaggattaataagagtgttcggtatagtgtaggctggagctgcttc), downstream primer 
JG2935 (gtccgtagttcttcgtaagccgtcatgattacaatctcaccatatgaatatcctccttag), upstream 
verification primer JG2936 (tcagcgacttctgttctattcaagtaagaaaggggtacgg), and downstream 
verification primer JG2937 (gctcctcactgacggacgtgcgaacgtcgtctagattatg). Antibiotic 
resistance markers were swapped out using pCP20 9. The mutant was verified via PCR 








2.2 Molecular and Genetic Typing of Acute and Chronic S. Typhi Strains 
 S. Typhi strains from Ohio and Mexico City were assayed for relatedness using 
Pulsed-field gel electrophoresis (PFGE). Fresh, isolated single colonies were added to 2 
ml of cell suspension buffer (CSB). The cells were re-suspended in 300 µl of Gram-
negative lysis buffer and dispensed into the plug molds. Plugs were digested using SmaI. 
The standard markers, Salmonella enterica BAA-664 plugs, were also digested using 
XbaI at the same time. PFGE parameters used were a gradient of 6, run time of 18 h 
(h=hours), included angle of 120, initial switch time of 5 s (s=seconds), and final switch 
time of 40 s. After the run was complete, the gel was stained using 5 µl/ml of ethidium 
bromide in distilled water and photographed using Gel Doc 2000 (Bio-Rad). Images were 
analyzed using Bionumerics 4.0 (applied Math) using a Dice similarity coefficient and an 
unweighted-pair group method using average linkages (UPGMA) dendrogram type. 
Position tolerance settings included optimization at 1.50% and position tolerance at 2.0%.  
 
Clinical S. Typhi strains acquired from Vietnam had been previously whole-
genome sequenced  before use in this study. All remaining isolates were whole-genome 
sequenced as part of a consortium with the U.S. Food and Drug Administration (FDA), 
who agreed to sequence 1,000 clinical isolates from the U.S., Mexico, Thailand, east 
Africa, and Brazil. The maximum-likelihood phylogenetic tree was built from the SNP 
alignment of all 22 isolates, S. Typhi Ty 2 (JSG698), and Typhimurium 14028s (JSG210) 
strain included as an outgroup for tree rooting, using RAxML (version 7.8.6)55 with the 
generalized time-reversible model and a Gamma distribution to model site-specific rate 






maximum-likelihood phylogeny was assessed via 100 bootstrap pseudoanalyses of the 
alignment data. 
 
2.3 Biofilm Growth and Crystal Violet Assays 
S. Typhi cultures were grown overnight (O/N) in TSB at 37 ˚C with aeration. 
Cultures were then normalized to OD490 = 0.65, diluted 1:6 in TSB, and incubated for 
3 hours at 37 ˚C, static. Bacteria were then diluted 1:2500 and 200 µl of the bacterial 
suspension were dispersed into non-treated polystyrene 96-well plates (Corning, 
Kennebunkport, ME). The plates were incubated at 30 ˚C in a GyroMini nutating 
mixer (LabNet International, Inc., NJ) at 24 rpm for 96 h. To simulate growth 
conditions on gallstones, wells were pre-coated with cholesterol by adding a solution 
of 5 mg/mL in 1:1 isopropanol:ethanol and air-dried overnight. Media was changed 
daily for biofilm growth. After 96 hours, plates were washed 4 times in ddH2O to 
eliminate planktonic cells. Biofilms were heat fixed 1 hour at 60 ˚C, stained with .33% 
crystal violet solution (6.0 ml PBS, 3.3 ml crystal violet, 333 µl methanol, 333 µl 
isopropanol) for 5 minutes, and released using 33% acetic acid (3.3 ml glacial acetic 
acid, 6.7 ml ddH2O) to quantify the stain. Biofilm quantification was performed by 
measuring the optical density (OD570) of the released dye in a SpectraMax 
spectrophotometer with SoftMax Pro software (Molecular Devices, Sunnyvale, CA) to 









2.4 Dot Blot Assay 
 Bacterial cultures were grown overnight in TSB at 37 ˚C with aeration, fixed in 
4% paraformaldehyde (PFA), and normalized to OD600 = 0.8 in PBS. Normalized 
cultures were then divided into a lysate group and a non-lysate group. Lysate cultures 
were boiled for 10 min to break apart the cells. Bacterial dilutions (1:6 for Vi antigen; 
1:20 and 1:50 for LPS) were prepared, spotting 200 µl onto methanol-activated PVDF 
membranes using a suction manifold device. The blots were dried and blocked at 4 ˚C 
O/N with 5% milk buffer, followed by incubation in either α-Vi-antigen (1:1000) or α–
LPS (1:1000). The blots were washed 3 times, 15 minutes each, in tris-buffered saline 
with polysorbate 20 (TBST) and incubated with anti-mouse (for LPS; 1:2:000) or anti-
rabbit (for Vi; 1:2000) horseradish peroxidase-conjugated secondary antibodies (Bio-
Rad) O/N at 4 ˚C prior to visualization using the Bio-Rad Chemi-Doc XRS system. 
 
2.5 Congo Red Assay 
 Congo Red agar plates were prepared using LB-no salt supplemented with Congo 
Red (40 µg/ml) and Coomassie Brilliant Blue (20 µg/ml). Bacterial suspensions were 
created from single colony streaks on LB agar plates, diluted 1:100 in LB-no salt, and 
normalized to OD600 = 5. Cultures were plated by dropping 5 µl onto the Congo Red 










2.6 Confocal Microscopy of Biofilms 
S. Typhi strains were inoculated from a frozen stock into TSB broth and grown 
overnight at 37°C with aeration. Cultures were then normalized to OD490 = 0.65, diluted 
1:6 in TSB, and incubated for 3 hours at 37 ˚C, static. Bacteria were then diluted 1:2,500 
and 200 µl of the bacterial suspension was added to each well of a LabTek II 8-well 
chambered coverglass (LabTek). Slides were incubated static for 16 hrs at 37°C in a 
humidified atmosphere at which time medium was aspirated and replaced with fresh TSB 
broth. After an additional 8 hrs (24 hrs total incubation time), medium was aspirated and 
replaced with fresh TSB broth. After an additional 16 hours (40 hours total incubation 
time), biofilms were then stained with LIVE/DEAD® BacLight™ Bacterial Viability kit 
for microscopy (Molecular Probes), then fixed with a solution of 16% paraformaldehyde- 
2.5% glutaraldehyde- 4% acetic acid in 0.2M phosphate buffer, pH 7.4, prior to 
immediate imaging by confocal microscopy. Z-stack images were collected via confocal 

















3.1 Molecular and Genetic Typing of Acute and Chronic S. Typhi Strains 
 S. Typhi isolates from Ohio and Mexico City were assayed for relatedness using 
Pulsed-field gel electrophoresis (PFGE). Subtyping by PFGE with the restriction 
enzymes XbaI and SmaI showed that isolates from Ohio had different banding patterns 
shown in Figure 1. Of the 11 isolates subtyped, there were a total of seven different 
PFGE patterns. Four acute carrier isolates from Ohio (JSG3400, JSG3418, JSG3419, and 
JSG3431) had unique banding patterns not shared by other isolates. Chronic carrier 
isolates from Mexico, JSG3074 and JSG3076, demonstrated identical PGFE patterns. 
Additionally, two pairs of Ohio acute isolates (JSG3433 and JSG3441; JSG3395 and 
JSG3407) also demonstrated identical PGFE patterns. Overall, the majority of isolates 
(90%) demonstrated high similarity according to PGFE phylogenetic analysis (≥85.7% 
similar). Ohio acute isolate JSG3400 was the most unique isolate from the group 
(≥64.2% similar).  
  
 In order to make better phylogenetic comparisons, we whole-genome sequenced 
all of the Ohio and Mexico City S. Typhi isolates under study, as well as newly acquired 
Vietnam isolates. The resulting maximum-likelihood phylogenetic tree is shown in 
Figure 2.  Clinical isolates displayed high genetic similarity with multiple tight clusters 
formed. Genome-sequencing analysis, as observed in the PFGE, also revealed acute 
JSG3400 as an outlier from the group. However, there were no clusters formed based on 






3.2 Crystal Violet Biofilm Studies 
In order to assess the general biofilm forming abilities of chronic carrier and acute 
isolates, we performed a biofilm assay on cholesterol-coated polypropylene plates for 96 
h. Cholesterol-coated plates mimic the cholesterol surface found on gallstones where 
biofilms are formed in chronic carriers. The strains examined included the eight chronic 
carrier isolates, 14 isolates from acute patients, WT S. Typhi, and a Vi-antigen mutant – 
JSG4123 (∆tviB). The crystal violet biofilm assay revealed variable biofilm formation 
across all isolates as illustrated in Figure 3. No patterns emerged regarding the site at 
which the strains were cultured in acutely or chronically infected patients.  
 
3.3 Dot Blot Assay 
 Comparison of the extracellular matrix components, Vi-antigen and 
lipopolysaccharide (LPS), of acute and chronic strains were completed by dot blot 
analysis. Dot blot studies of Vi-antigen revealed variable expression across all isolates 
shown in Figure 4A. Negative controls included JSG210 (S. Typhimurium) and Vi-
antigen mutants JSG4123 and JSG1213. There was no clear pattern of expression 
between acute or chronic isolates. Acute isolates JSG3989, JSG3395, and JSG3418 
demonstrated high Vi-antigen expression on the whole cell, while chronic isolates 
JSG3983 and JSG3982 also revealed high whole cell Vi expression. Additionally, WT S. 
Typhi demonstrated high whole cell detection of Vi-antigen. All remaining clinical 
isolates, both acute and chronic, demonstrated weak to no Vi-antigen detection. This 
result was additionally confirmed by Vi agglutination tests (data not shown). In many 







LPS detection by dot blots (Figure 4B) also revealed variable expression on both 
the surface and in the lysate preparations. Like the Vi-antigen assay, there was no clear 
pattern of expression when comparing acute and chronic isolates. Acute isolate strains 
JSG3989, JSG3987, and JSG3400 demonstrated high LPS expression both on the surface 
and in the lysate preparations. However, there was no LPS detected in either preparations 
in chronic carrier isolate strains JSG3074, the Vi-mutant JSG4123, JSG3982, and acute 
isolate strain JSG3407. LPS was only detected in the lysate of the remaining isolates. WT 
S. Typhi had low whole cell detection of LPS with high detection in the lysate 
preparation. However, high levels of LPS were detected on the surface of the WT S. 
Typhi Vi mutant, JSG1213.  
 
3.4 Confocal Microscopy Examination of Biofilms 
 To examine if there were differences in biofilm architecture between chronic and 
acute isolates, we utilized confocal microscopy to measure thickness (µm) and biomass 
(µm3/µm2). Z-stack images were captured of chronic and acute isolate biofilms grown for 
40h and analyzed with COMSTAT2© software. In measurements of average thickness, 
chronic carrier isolates formed thicker biofilms than acute isolates as shown in Figure 5. 










3.5 Cellulose and Curli Fimbriae Detection  
 To detect cellulose and curli fimbriae in the isolates,  a Congo red (CR) binding 
assay was utilized (Figure 7). CR is a hallmark amyloid-binding dye that binds to curli, as 
well as to cellulose. JSG210 (S. Typhimurium) is known to produce high levels of curli 
and cellulose; therefore, it was used as a positive control. Clinical isolates plated on CR 
agar did not demonstrate the red, dry, and rough (rdar) phenotype compared to S. 
Typhimurium. However, S. Typhi WT and clinical isolates were pink, dry, and rough 
(pdar), suggesting that they produce cellulose but not as much curli as S. Typhimurium. 
There were variable morphotypes between the colonies, but no clear pattern emerged 

































The spread of S. Typhi is dependent on the chronic carrier state during which 
fecal shedding allows bacteria to spread to new hosts through contamination of water 
sources. The S. Typhi chronic carriage state includes the formation of biofilm 
communities on the surface of gallstones in the gallbladder. Further understanding of the 
biological mechanisms involved in carriage is critical to impeding the burden of typhoid 
fever.  
 
Differences in S. Typhi isolates may account for clinical outcomes in patients. In 
this present study, we hypothesized that phenotypic and genomic differences exist 
between acute and chronic clinical isolates of S. Typhi. This hypothesis was tested by (1) 
examination of biofilm formation of acute and chronic strains, (2) comparison of the 
exopolysaccharide matrix components of acute and chronic strains, (3) analysis of the 
molecular and genetic typing of acute and chronic S. Typhi strains.  
 
4.1 Molecular and genetic typing of acute and chronic S. Typhi strains 
In a preliminary study, we conducted Pulsed-Field Gel Electrophoresis (PFGE) of 
clinical isolates from the Ohio Department of Health and Mexico City. PFGE analysis 
revealed high genetic similarity between a majority of the isolates (85.7% similar), with 
one acute isolate, JSG3400, being a unique outlier from the group (64.2% similar to the 
group). To make more accurate phylogenetic comparisons, our isolates were whole-






between strains, confirming the results seen in the PFGE analysis. Similar to the PFGE 
result, JSG3400 was revealed as an outlier from the group in the whole-genome 
sequencing analysis. Phylogenetic comparisons of the sequences revealed that isolates 
were not clustered based on geography or carrier status.  
 
The stability of the S. Typhi genome and relatedness of clinical strains, however, 
is a heavily debated topic. Previous studies have characterized the S. Typhi genome as 
highly clonal. Similarly, isolates from acute and chronic infections have been shown to 
exhibit minimal genetic variation or recombination 10, 11. Despite this, some studies have 
reported conflicting data, such as the presence of variant S. Typhi strains with novel 
pathogenic elements and chromosomal rearrangements12, 13. Furthermore, chronic carriers 
have even been shown to simultaneously excrete S. Typhi strains with considerable 
genetic variation14. While genomic variants of S. Typhi may exist, our data suggests that 
clinical isolates, regardless of geography or infection status, are closely related and clonal 
in nature. However, as shown in the PFGE and maximum-relatedness tree, acute isolate 
JSG3400 did demonstrate genomic variability with aligns with the perspective that S. 
Typhi is not as clonal as we once believed.  
 
4.2 Examination of Biofilm Formation  
 To characterize general biofilm forming abilities of the acute and chronic isolates, 
we utilized a crystal violet biofilm assay on cholesterol-coated 96-well polystyrene plates 






formation from both acute and chronic carrier isolates, with neither group forming 
superior biofilms than the other.  
 
 We further examined the biofilm forming abilities of the isolates, utilizing 
confocal microscopy. Z-stack images captured the biofilm architecture, measuring both 
thickness (µm) and biomass (µm3/µm2). Despite what crystal violet biofilm studies 
showed, chronic carrier isolates, on average, formed higher levels of biofilm by the 
measurements previously described. These data indicate that carrier isolates are able to 
form superior biofilms despite high genetic similarity to acute isolates. The crystal violet 
assay has a lot of utility as an easy and rapid biofilm measuring technique, which merits 
its use primarily in the high-throughput screening of anti-biofilm compounds. However, 
because the technique measures the retention of dye, it does not allow for the precise 
measurement of biofilm architecture. While our crystal violet data suggests that there is 
no difference in the biofilm forming abilities of S. Typhi clinical isolates, we are inclined 
to trust the more sensitive approach of confocal microscopy which demonstrated a 
remarkable difference in both the thickness and biomass of the biofilms.  
  
4.3 Extracellular Matrix Studies  
 In this study, we used dot blots to compare the extracellular matrix components 
Vi-antigen and lipopolysaccharide (LPS) of acute and chronic strains. The production of 
Vi-antigen by S. Typhi is a distinguishing feature of the bacterium and the detection of Vi 
by agglutination is a common diagnostic procedure. Vi-antigen has been shown to have 






been shown to prevent complement receptor 3 (CR-3) dependent clearance and reduce 
bacterial-guided neutrophil chemotaxis through multiple pathways 16,17,18. LPS is a major 
component of the outer membrane in gram-negative bacteria and plays a vital role in 
host-pathogen interactions with the innate immune system 19.  
 
 Dot blot assays of Vi-antigen expression revealed variable expression in both 
acute and chronic isolates. Three acute isolates (JSG3989, JSG3395, and JSG3418) and 
two chronic isolates (JSG3983 and JSG3982) demonstrated high Vi detection on the 
surface of the cell. WT S. Typhi (Ty 2) also demonstrated high Vi expression. The 
majority of the clinical isolates, both acute and chronic, expressed low Vi-antigen or were 
Vi-negative, despite testing positive for Vi by an agglutination test when the strains were 
originally received (data not shown). S. Typhi isolates lacking Vi-antigen have previously 
been reported, and it is thought that long-term storage of strains may lead to Vi-positive 
strains becoming Vi-negative 20. However, strains that tested negative by the dot blot 
assay and agglutination test, were confirmed to be Vi-positive by PCR of the tviB gene. 
These data suggest that either Vi is missing due to mutations in the genes encoding Vi-
antigen or that Vi is potentially modified and expression is regulated differently in 
various strains, despite how genetically similar whole-genome sequencing demonstrated 
these strains to be.  
 
LPS dot blots were meant to be a control that should show uniformity across all 
isolates, but instead revealed unexpected variable expression on both the whole cell and 






was present, but not being detectable on the surface due to modifications or steric 
hindrance by another surface molecule. While no clear pattern of LPS expression was 
seen in the acute or chronic group, only three acute isolates (JSG3989, JSG3987, and 
JSG3400) had detectable LPS on the surface of the cell. While WT S. Typhi had 
detectable levels of LPS on the surface, the Vi mutant of WT S. Typhi (JSG1213) had 
increased surface levels of LPS, suggesting that high Vi-antigen expression may be 
sterically blocking LPS detection. However, this same result was not seen in the chronic 
isolate JSG3074 and the chronic carrier Vi-mutant JSG4123 (∆tviB). There was low Vi-
antigen baseline expression for chronic isolate JSG3074 prior to Vi deletion, possibly 
suggesting that Vi antigen needs to be more abundant in order to block surface LPS 
detection. However, acute isolate JSG3939 showed both high levels of Vi and LPS 
suggesting that high Vi does not always correlate with low or no LPS detection.  
 
Modifications made to the LPS molecule may be responsible for the lack of 
detection. LPS is known to be a key virulence factor in host–pathogen interactions and in 
the establishment of chronic infections. Previous studies have shown that alterations in 
the LPS molecule (e.g. modifications to the O antigen) contribute to host colonization, 
immune defense evasion, and adaptation to the infection niche19,21,22.  
 
Finally, we looked at cellulose and curli fimbriae production utilizing a Congo red 
assay. As filamentous appendages, curli fimbriae have highly adhesive properties and are 
an important component in the extracellular matrix. These fibers, along with cellulose 






cells to surfaces, cell aggregation, pellicle formation, and biofilm formation 23,24, 25, 26, 27. 
All 22 clinical isolates demonstrated a pink, dry, and rough (pdar) phenotype which is 
indicative of cellulose production but low curli production. S. Typhimurium however, 
demonstrated high levels of both curli and cellulose with a characteristic rough, dry, and 
red (rdar) phenotype. There was however, unexpected variability in the colony 
morphotypes as well.  
4.4 Conclusions and Future Directions 
 In conclusion, these data suggest that despite the high genetic similarity seen 
between these clinical isolates, there is considerable phenotypic variability. While much 
of this variability could not be assigned to carrier status, chronic carrier isolates did 
demonstrate superior biofilm formation than the acute isolates. In future studies, we hope 
to elucidate the mechanism behind this result. Validation of the Vi-antigen and LPS dot 
blot data with immunofluorescence microscopy is also ongoing. After this, we would like 
to characterize the specific mutation or modifications made to both of these extracellular 
molecules. Overall, it is our hope that the findings outlined in this thesis will lead to a 
better understanding of the chronic carrier state of S. Typhi, and may one day yield 












Table 1Table 1. Bacterial strains and relevant characteristics 
 
Strain Characteristics Reference 
JSG698 S. Typhi Ty2; wild-type ATCC 
JSG1213 S. Typhi Ty2 tviB::Kan Gift of Popoff lab 
JSG210 S. Typhimurium 14028s; wild-type ATCC 
JSG4123 JSG3074 ∆tviB via Wanner This study 
JSG3990 S. Typhi isolate; acute infection; 
Vietnam 
Gift of S. Baker 
JSG3989 S. Typhi isolate, acute infection; 
Vietnam 
Gift of S. Baker 
JSG3988 S. Typhi isolate, acute infection; 
Vietnam 
Gift of S. Baker 
JSG3987 S. Typhi isolate, acute infection; 
Vietnam 
Gift of S. Baker 
JSG3986 S. Typhi isolate, acute infection; 
Vietnam 
Gift of S. Baker 
JSG3985 S. Typhi isolate, acute infection; 
Vietnam 
Gift of S. Baker 
JSG3984 S. Typhi isolate, chronic carrier; 
Vietnam 
Gift of S. Baker 
JSG3983 S. Typhi isolate, chronic carrier; 
Vietnam 
Gift of S. Baker 
JSG3982 S. Typhi isolate, chronic carrier; 
Vietnam 
Gift of S. Baker 
JSG3981 S. Typhi isolate, chronic carrier; 
Vietnam 
Gift of S. Baker 
JSG3980 S. Typhi isolate, chronic carrier; 
Vietnam 
Gift of S. Baker 
JSG3979 S. Typhi isolate, chronic carrier; 
Vietnam 
Gift of S. Baker 
JSG3074 S. Typhi isolate, chronic carrier; 
Mexico City, Mexico 
General Hospital of Mexico 
JSG3076 S. Typhi isolate, chronic carrier; 
Mexico City, Mexico 
General Hospital of Mexico 
JSG3395 S. Typhi isolate, acute infection; Ohio 
(blood) 
Ohio Department of Health 
JSG3400 S. Typhi isolate, acute infection; Ohio 
(bile) 
Ohio Department of Health 
JSG3407 S. Typhi isolate, acute infection; Ohio 
(stool) 
Ohio Department of Health 
JSG3418 S. Typhi isolate, acute infection; Ohio 
(stool) 
Ohio Department of Health 
JSG3419 S. Typhi isolate, acute infection; Ohio 
(blood) 
Ohio Department of Health 
JSG3431 S. Typhi isolate, acute infection; Ohio 
(stool) 
Ohio Department of Health 
JSG3433 S. Typhi isolate, acute infection; Ohio 
(blood)  
Ohio Department of Health 
JSG3441 S. Typhi isolate, acute infection; Ohio 
(stool) 


























Figure 1. Model of S. Typhi chronic carriage. A) Electron micrograph of S. Typhi in a biofilm on the 
surface of a human gallstone. B) Schematic of S. Typhi biofilm formation on cholesterol gallstones in the 
gallbladder and shedding of bacteria. C) Schematic of S. Typhi infecting gallbladder epithelium, which leads 
to extrusion and shedding. Gonzalez-Escobedo G, Marshall JM, Gunn JS. Chronic and acute infection of the 
















Figure 2. Results of Pulsed-Field Gel Electrophoresis (PFGE). Dendrogram showing genetic 
relationships among 10 S. Typhi clinical isolate strains based on PFGE patterns. The strains were 






Figure 3. Maximum-likelihood phylogenetic tree. Dendrogram showing genetic relationships among all S. Typhi 
clinical isolate strains (CC: chronic carrier; AI: acute isolate) and JSG698 (WT) based on whole-genome sequences. 
















































Figure 4. Analysis of biofilms with the crystal violet assay. Results of crystal violet biofilm assay with 
all 22 S. Typhi clinical isolates, JSG698 (WT), and JSG4123 (∆tviB). Biofilms were visualized with 
crystal violet dye after 96h. Chronic carrier isolates are shown in black and acute isolates in charcoal. This 







Figure 5. Results of dot blot assay. A) Image of Vi-antigen dot blot assay with all 22 clinical 
isolates (CC: chronic carrier; AI: acute isolate), JSG698 (WT), negative-control strain JSG210 (S. 
Typhimurium; ctl: control), and Vi-mutants JSG4123 and JSG1213. Whole cell and lysate 
preparations were diluted 1:6 in 1X PBS after normalization, division, and lysis step. B) Image of 



























Figure 5. Confocal analysis of biofilms. Average thickness (µm) of all clinical isolates (CC: chronic carrier; 
AI: acute isolate) and JSG698 (WT). Chronic carrier isolates are shown in blue and acute isolates are shown in 
red. Z-stack images were captured of chronic and acute isolate biofilms grown for 40h and analyzed with 

















































Figure 6. Confocal analysis of biofilms. Average biomass (µm3/µm2) of all clinical isolates (CC: chronic 
carrier; AI: acute isolate) and JSG698 (WT). Chronic carrier isolates are shown in blue and acute isolates are 
shown in red. Averages of each group, carrier and acute isolates, are seen marked by dashed-line. Z-stack 




























Figure 7. Congo Red Agar Assay. Images of all 22 clinical isolates (CC: chronic carrier; AI: acute 
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